首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Correlation of ultrasound with histopathology for retained products of conception in medically managed abortions
【24h】

Correlation of ultrasound with histopathology for retained products of conception in medically managed abortions

机译:超声与组织病理学在药物流产中保留的受孕产物的相关性

获取原文
           

摘要

Background: Medical abortion uses an anti-progestin, mifepristone (RU486), followed by a prostaglandin (misoprostol). Objective of present study was to correlate findings of transvaginal ultrasound with histopathology for retained products of conception in medical abortions. Methods: An observational, prospective study was conducted on hundred women with gestation upto 12 weeks who underwent medical abortion with excessive or prolonged post abortal vaginal bleeding. Transvaginal scan followed by uterine evacuation was done under anesthesia, followed by histopathology. Results: Analysis was done statistically using Pearson Chi- square method. Sixty five percent subjects took MTP pill by unsupervised, self-intake and 35% on prescription. Among women who took misoprostol in dose of 400mcg, 89% had RPOC on histopathology. At the dose of 800 mcg, 73.3% had retained Products of Conception (RPOC) on histopathology. The correlation was found to be statistically non-significant (p value at 5% was 1.13). Ultrasound showed echogenic mass in the uterine cavity in 62 (62%) women, increased endometrial thickness ≥10mm in 13 (13%), gestational sac with no fetal pole in 6 (6%), blood clots in uterine cavity in 6 (6%), and empty uterine cavity in 3 (3%). Seventy five percent of women had histologically proven RPOC at endometrial cut off of equal to or greater than 10mm. The sensitivity, specificity, positive and negative predictive value of transvaginal ultrasonography in detection of retained products of conception were 92%, 60%, 87.3%, 71.4% respectively. The diagnostic accuracy was 84%. Conclusions: Transvaginal ultrasound for detecting retained products of conception in medically managed abortions has a high sensitivity and positive predictive value and is useful for screening women with clinically suspected incomplete abortion who require further intervention -medical or surgical.
机译:背景:药物流产使用抗孕激素米非司酮(RU486),然后使用前列腺素(米索前列醇)。本研究的目的是将经阴道超声检查的结果与组织病理学联系起来,以保留药物流产中的受孕残留物。方法:一项观察性,前瞻性研究是对数百名妊娠至12周的孕妇进行的,她们因流产后阴道流血过多或延长而进行了药物流产。在麻醉下进行阴道扫描,然后进行子宫排空,然后进行组织病理学检查。结果:使用Pearson卡方方法进行统计学分析。 65%的受试者在无人监督的情况下自行服用MTP药,处方药占35%。在服用米索前列醇400mcg的女性中,有89%的组织病理学上有RPOC。以800 mcg的剂量,有73.3%的组织病理学保留了受孕产物(RPOC)。发现相关性在统计上不显着(5%的p值为1.13)。超声检查发现62例(62%)妇女子宫腔内有回声块,13例(13%)子宫内膜厚度增加≥10mm,6例(6%)无胎儿极的胎囊,6例子宫腔内血凝块(6) %),并在3(3%)中排空子宫腔。经组织学证实,有75%的女性子宫内膜切除处的RPOC等于或大于10mm。经阴道超声检查对妊娠残留物的敏感性,特异性,阳性和阴性预测值分别为92%,60%,87.3%,71.4%。诊断准确性为84%。结论:经阴道超声检测药物流产的保留的妊娠产物具有很高的敏感性和积极的预测价值,对于筛查临床怀疑不完全流产的妇女,这些妇女需要进一步的医学或手术干预非常有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号